KOSDAQ-listed pharmaceutical firms' profits dipped

Published: 2003-03-20 06:58:00

Updated: 2003-03-20 06:58:00

According to statistics compiled by Yakup Shinmoon, 13 KOSDAQ-listed pharmaceutical firms including Kyungdong Pharm posted a combined turnover of 387.4 billion won in 2002, or an increase of 14.5 percent over the previous year but their net incomes amounted to 40.7 billion won, down 15 percent. T...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK